USPTO serial 79365432
CARTREVIVE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 30, 2024
- Examiner
- FRENCH, CURTIS W
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CARTREVIVE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bradley M. Stohry
Bradley M. Stohry Reichel Stohry Dean LLP6151 Central AveIndianapolis, IN 46220United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical compositions for cartilage repair and treatments; pharmaceutical compositions for pain management and inflammation reduction; pharmaceutical compositions for bone repair; pharmaceutical gels for cartilage repair and treatments; pharmaceutical gels for pain management and inflammation reduction; pharmaceutical gels for bone repair; injectable pharmaceuticals for cartilage repair and treatments; injectable pharmaceuticals for pain management and inflammation reduction; injectable pharmaceuticals for bone repair; pharmaceutical products containing liquid polymers for cartilage repair and treatments; pharmaceutical products containing liquid polymers for pain management and inflammation reduction; pharmaceutical products containing liquid polymers for bone repair; pharmaceutical products containing hydrogels for cartilage repair and treatments; pharmaceutical products containing hydrogels for pain management and inflammation reduction; pharmaceutical products containing hydrogels for bone repair; advanced therapy medicinal products for cartilage repair and treatments; advanced therapy medicinal products for pain management and inflammation reduction; advanced therapy medicinal products for bone repair; advanced therapy medicinal products containing liquid polymers for cartilage repair and treatments; advanced therapy medicinal products containing liquid polymers for pain management and inflammation reduction; advanced therapy medicinal products containing liquid polymers for bone repair; advanced therapy medicinal products containing hydrogels for cartilage repair and treatments; advanced therapy medicinal products containing hydrogels for pain management and inflammation reduction; advanced therapy medicinal products containing hydrogels for bone repair; biological tissue cultures for medical purposes; medicated hydrogels for cartilage repair and treatments; medicated hydrogels for pain management and inflammation reduction; medicated hydrogels for bone repair; medicated hydrogels resorbable by the human body for cartilage repair and treatments; medicated hydrogels resorbable by the human body for pain management and inflammation reduction; medicated hydrogels resorbable by the human body for bone repair; pharmaceutical products for cartilage repair and treatments; pharmaceutical products for pain management and inflammation reduction; pharmaceutical products for bone repair; injectable dermal fillers; dental fillers, namely, teeth filling material; surgical glues and sealants | ACTIVE | — |
| 010 | Medical devices, namely, injection needles; medical devices, namely, syringes; medical devices for injection of liquid components in the human body, namely, injection needles; medical devices for injection of liquid polymers in the human body, namely, injection needles; medical devices for injection of hydrogels in the human body, namely, injection needles; medical devices for supply of pharmaceutical products for cartilage repair to the human body, namely, injection instruments with needles; medical devices for supply of pharmaceutical products for bone repair to the human body, namely, injection instruments with needles; medical devices for supply of dermal fillers to the human body; medical devices for supply of dental fillers to the human body, namely, injection needles; medical devices for supply of dental fillers to the human body, namely, syringes; medical devices for application of surgical glues and sealants to the human body; diagnostic apparatus for medical purposes, namely, ultrasound diagnostic apparatus; diagnostic apparatus for medical purposes, namely, X-ray diagnostic apparatus; cell culture instruments for medical use, namely, cell culture chambers | ACTIVE | — |
| 044 | Medical services, namely, cartilage repair in the human body; medical services, namely, pain management and inflammation reduction in the human body; medical services, namely, bone repair in the human body; dermatology services for the human body; dentistry services for the human body; surgical treatment services, namely, surgery of the human body; medical services for the diagnosis of conditions of the human body; drug screening of the human body for medical purposes; drug screening of the human body for medical purposes involving application of liquid polymers; drug screening of the human body for medical purposes involving application of hydrogels | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Hy2Care B.V.
- Other trademarks owned by Hy2Care B.V.
- Other trademarks owned by Hy2Care B.V.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named CARTREVIVE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 24, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 6, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 21, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 21, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 21, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 21, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 21, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 17, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 29, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 28, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 30, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 30, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 30, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 14, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 13, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 13, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 24, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 24, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 24, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 5, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 28, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 27, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 27, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 2, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 13, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 13, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 8, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 7, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 5, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 24, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 20, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 16, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |